InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,297.10
(
-0.21%
)
US TECH 100
18,079.20
(
0.00%
)
Dow Jones
39,869.38
(
-0.10%
)
Brent Oil
83.42
(
0.25%
)
Bitcoin
66,168.12
(
1.42%
)
Post# of 144813
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JODI1

Send PM Follow Ignore
Followers 4
Posts 590
Boards Moderated 0
Alias Born 05/22/2012

JODI1

Re: None

Sunday, 11/17/2019 3:36:48 PM

Sunday, November 17, 2019 3:36:48 PM

Post# of 144813
The reason why PMCB is a crowd pleaser to big pharma is that its pancreatic cancer treatment CIAB will outperform Eli Lilly’s option, which failed to maintain goal of survival in recent trial.

The darkest hour is just before dawn...

Kaboom $$$!!
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News
InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM

Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM

Start posting your company's news
Only $200 per official company press release!